Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Nuclear Medicine/Radiopharmaceutic market report explains the definition, types, applications, major countries, and major players of the Nuclear Medicine/Radiopharmaceutic market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Lantheus Medical Imaging
Ciaeriar
Nordion
Shanghai Atom Kexing
GE Healthcare
China Isotope Radiation
Iba Molecular Imaging
Cardinal Health
Jaco
Bracco Imaging
Advanced Accelerator Applications
Mallinckrodt
Dongcheng
Bayer Healthcare
Eczacibasi-Monrol Nuclear Products
Advanced Molecular-imaging Solution
By Type:
Diagnostic
Therapeutic
By End-User:
Oncology
Thyroid
Cardiology
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Nuclear Medicine/Radiopharmaceutic Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Nuclear Medicine/Radiopharmaceutic Outlook to 2028- Original Forecasts
-
2.2 Nuclear Medicine/Radiopharmaceutic Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Nuclear Medicine/Radiopharmaceutic Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Nuclear Medicine/Radiopharmaceutic Market- Recent Developments
-
6.1 Nuclear Medicine/Radiopharmaceutic Market News and Developments
-
6.2 Nuclear Medicine/Radiopharmaceutic Market Deals Landscape
7 Nuclear Medicine/Radiopharmaceutic Raw Materials and Cost Structure Analysis
-
7.1 Nuclear Medicine/Radiopharmaceutic Key Raw Materials
-
7.2 Nuclear Medicine/Radiopharmaceutic Price Trend of Key Raw Materials
-
7.3 Nuclear Medicine/Radiopharmaceutic Key Suppliers of Raw Materials
-
7.4 Nuclear Medicine/Radiopharmaceutic Market Concentration Rate of Raw Materials
-
7.5 Nuclear Medicine/Radiopharmaceutic Cost Structure Analysis
-
7.5.1 Nuclear Medicine/Radiopharmaceutic Raw Materials Analysis
-
7.5.2 Nuclear Medicine/Radiopharmaceutic Labor Cost Analysis
-
7.5.3 Nuclear Medicine/Radiopharmaceutic Manufacturing Expenses Analysis
8 Global Nuclear Medicine/Radiopharmaceutic Import and Export Analysis (Top 10 Countries)
-
8.1 Global Nuclear Medicine/Radiopharmaceutic Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Nuclear Medicine/Radiopharmaceutic Export by Region (Top 10 Countries) (2017-2028)
9 Global Nuclear Medicine/Radiopharmaceutic Market Outlook by Types and Applications to 2022
-
9.1 Global Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Diagnostic Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Therapeutic Consumption and Growth Rate (2017-2022)
-
9.2 Global Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Thyroid Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Cardiology Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Nuclear Medicine/Radiopharmaceutic Market Analysis and Outlook till 2022
-
10.1 Global Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.2.2 Canada Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.2.3 Mexico Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.3.2 UK Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.3.3 Spain Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.3.4 Belgium Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.3.5 France Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.3.6 Italy Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.3.7 Denmark Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.3.8 Finland Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.3.9 Norway Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.3.10 Sweden Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.3.11 Poland Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.3.12 Russia Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.3.13 Turkey Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.4.2 Japan Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.4.3 India Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.4.4 South Korea Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.4.5 Pakistan Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.4.6 Bangladesh Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.4.7 Indonesia Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.4.8 Thailand Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.4.9 Singapore Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.4.10 Malaysia Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.4.11 Philippines Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.4.12 Vietnam Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.5.2 Colombia Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.5.3 Chile Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.5.4 Argentina Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.5.5 Venezuela Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.5.6 Peru Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.5.7 Puerto Rico Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.5.8 Ecuador Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.6.2 Kuwait Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.6.3 Oman Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.6.4 Qatar Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.6.5 Saudi Arabia Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.6.6 United Arab Emirates Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.7.2 South Africa Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.7.3 Egypt Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.7.4 Algeria Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
-
10.8.2 New Zealand Nuclear Medicine/Radiopharmaceutic Consumption (2017-2022)
11 Global Nuclear Medicine/Radiopharmaceutic Competitive Analysis
-
11.1 Lantheus Medical Imaging
-
11.1.1 Lantheus Medical Imaging Company Details
-
11.1.2 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
11.1.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Ciaeriar
-
11.2.1 Ciaeriar Company Details
-
11.2.2 Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Ciaeriar Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
11.2.4 Ciaeriar Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Nordion
-
11.3.1 Nordion Company Details
-
11.3.2 Nordion Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Nordion Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
11.3.4 Nordion Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Shanghai Atom Kexing
-
11.4.1 Shanghai Atom Kexing Company Details
-
11.4.2 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
11.4.4 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 GE Healthcare
-
11.5.1 GE Healthcare Company Details
-
11.5.2 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
11.5.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 China Isotope Radiation
-
11.6.1 China Isotope Radiation Company Details
-
11.6.2 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
11.6.4 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Iba Molecular Imaging
-
11.7.1 Iba Molecular Imaging Company Details
-
11.7.2 Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
11.7.4 Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Cardinal Health
-
11.8.1 Cardinal Health Company Details
-
11.8.2 Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Cardinal Health Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
11.8.4 Cardinal Health Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Jaco
-
11.9.1 Jaco Company Details
-
11.9.2 Jaco Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Jaco Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
11.9.4 Jaco Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Bracco Imaging
-
11.10.1 Bracco Imaging Company Details
-
11.10.2 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
11.10.4 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Advanced Accelerator Applications
-
11.11.1 Advanced Accelerator Applications Company Details
-
11.11.2 Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
11.11.4 Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Mallinckrodt
-
11.12.1 Mallinckrodt Company Details
-
11.12.2 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
11.12.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Dongcheng
-
11.13.1 Dongcheng Company Details
-
11.13.2 Dongcheng Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Dongcheng Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
11.13.4 Dongcheng Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Bayer Healthcare
-
11.14.1 Bayer Healthcare Company Details
-
11.14.2 Bayer Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Bayer Healthcare Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
11.14.4 Bayer Healthcare Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Eczacibasi-Monrol Nuclear Products
-
11.15.1 Eczacibasi-Monrol Nuclear Products Company Details
-
11.15.2 Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
11.15.4 Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Advanced Molecular-imaging Solution
-
11.16.1 Advanced Molecular-imaging Solution Company Details
-
11.16.2 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
11.16.4 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
11.16.5 Recent Research and Development Strategies
12 Global Nuclear Medicine/Radiopharmaceutic Market Outlook by Types and Applications to 2028
-
12.1 Global Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Diagnostic Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Thyroid Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Nuclear Medicine/Radiopharmaceutic Market Analysis and Outlook to 2028
-
13.1 Global Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.2.2 Canada Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.2.3 Mexico Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.3.2 UK Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.3.3 Spain Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.3.4 Belgium Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.3.5 France Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.3.6 Italy Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.3.7 Denmark Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.3.8 Finland Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.3.9 Norway Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.3.10 Sweden Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.3.11 Poland Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.3.12 Russia Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.3.13 Turkey Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.4.2 Japan Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.4.3 India Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.4.4 South Korea Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.4.8 Thailand Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.4.9 Singapore Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.4.11 Philippines Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.5.2 Colombia Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.5.3 Chile Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.5.4 Argentina Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.5.6 Peru Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.6.3 Oman Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.6.4 Qatar Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.7.2 South Africa Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.7.3 Egypt Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.7.4 Algeria Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Nuclear Medicine/Radiopharmaceutic Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Nuclear Medicine/Radiopharmaceutic
-
Figure of Nuclear Medicine/Radiopharmaceutic Picture
-
Table Global Nuclear Medicine/Radiopharmaceutic Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Nuclear Medicine/Radiopharmaceutic Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Diagnostic Consumption and Growth Rate (2017-2022)
-
Figure Global Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Thyroid Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiology Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Nuclear Medicine/Radiopharmaceutic Consumption by Country (2017-2022)
-
Table North America Nuclear Medicine/Radiopharmaceutic Consumption by Country (2017-2022)
-
Figure United States Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Canada Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Mexico Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Table Europe Nuclear Medicine/Radiopharmaceutic Consumption by Country (2017-2022)
-
Figure Germany Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure UK Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Spain Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Belgium Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure France Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Italy Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Denmark Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Finland Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Norway Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Sweden Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Poland Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Russia Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Turkey Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Table APAC Nuclear Medicine/Radiopharmaceutic Consumption by Country (2017-2022)
-
Figure China Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Japan Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure India Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure South Korea Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Thailand Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Singapore Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Philippines Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Table South America Nuclear Medicine/Radiopharmaceutic Consumption by Country (2017-2022)
-
Figure Brazil Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Colombia Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Chile Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Argentina Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Peru Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Table GCC Nuclear Medicine/Radiopharmaceutic Consumption by Country (2017-2022)
-
Figure Bahrain Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Oman Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Qatar Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Table Africa Nuclear Medicine/Radiopharmaceutic Consumption by Country (2017-2022)
-
Figure Nigeria Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure South Africa Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Egypt Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure Algeria Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Table Oceania Nuclear Medicine/Radiopharmaceutic Consumption by Country (2017-2022)
-
Figure Australia Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Nuclear Medicine/Radiopharmaceutic Consumption and Growth Rate (2017-2022)
-
Table Lantheus Medical Imaging Company Details
-
Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
Table Ciaeriar Company Details
-
Table Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ciaeriar Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
Table Ciaeriar Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
Table Nordion Company Details
-
Table Nordion Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nordion Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
Table Nordion Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
Table Shanghai Atom Kexing Company Details
-
Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
Table GE Healthcare Company Details
-
Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
Table China Isotope Radiation Company Details
-
Table China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
Table China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
Table Iba Molecular Imaging Company Details
-
Table Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
Table Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
Table Cardinal Health Company Details
-
Table Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cardinal Health Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
Table Cardinal Health Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
Table Jaco Company Details
-
Table Jaco Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jaco Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
Table Jaco Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
Table Bracco Imaging Company Details
-
Table Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bracco Imaging Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
Table Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
Table Advanced Accelerator Applications Company Details
-
Table Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
Table Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
Table Mallinckrodt Company Details
-
Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
Table Dongcheng Company Details
-
Table Dongcheng Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dongcheng Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
Table Dongcheng Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
Table Bayer Healthcare Company Details
-
Table Bayer Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Healthcare Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
Table Bayer Healthcare Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
Table Eczacibasi-Monrol Nuclear Products Company Details
-
Table Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
Table Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
Table Advanced Molecular-imaging Solution Company Details
-
Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Main Business and Markets Served
-
Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Product Portfolio
-
Figure Global Diagnostic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Thyroid Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nuclear Medicine/Radiopharmaceutic Consumption Forecast by Country (2022-2028)
-
Table North America Nuclear Medicine/Radiopharmaceutic Consumption Forecast by Country (2022-2028)
-
Figure United States Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Nuclear Medicine/Radiopharmaceutic Consumption Forecast by Country (2022-2028)
-
Figure Germany Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Nuclear Medicine/Radiopharmaceutic Consumption Forecast by Country (2022-2028)
-
Figure China Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Nuclear Medicine/Radiopharmaceutic Consumption Forecast by Country (2022-2028)
-
Figure Brazil Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Nuclear Medicine/Radiopharmaceutic Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Nuclear Medicine/Radiopharmaceutic Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Nuclear Medicine/Radiopharmaceutic Consumption Forecast by Country (2022-2028)
-
Figure Australia Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Nuclear Medicine/Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)
-
